COVID-19大流行期间成人免疫性血小板减少症管理的实用指导
本文旨在为COVID-19大流行期间血小板减少症患者(尤其免疫性血小板减少症(ITP))的评估与管理提供实用指导。文件由关注ITP或凝血障碍的临床医生共识撰写并经英国ITP论坛成员审阅,虽提供推荐但非正式指南,且无充分证据表明替代治疗方法不正确。
要点
- 本文为COVID-19大流行期间ITP成人患者管理提供实用共识指导。
- 推荐由关注ITP或凝血障碍的临床医生共识撰写,并经英国ITP论坛成员审阅。
- 本文非正式指南,无充分证据断定替代治疗方法不正确。
核心结论
- 本文旨在为COVID-19大流行期间血小板减少症(尤其ITP)患者提供评估与管理实用指导,支持临床医生工作。
研究设计与样本
- 由关注ITP或凝血障碍的临床医生撰写共识,并经英国ITP论坛成员审阅。
临床怎么用
- 本文虽提供推荐,但非正式指南,无充分证据断定替代治疗方法不正确。
局限性
- 本文非正式指南,无充分证据基础断定替代治疗方法不正确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID-19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum.
引用
- Pavord S, Thachil J, Hunt BJ, et al. Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic. Br J Haematol. 2020. PMID: 32374026. doi:10.1111/bjh.16775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。